JP2021070677A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021070677A5 JP2021070677A5 JP2019200346A JP2019200346A JP2021070677A5 JP 2021070677 A5 JP2021070677 A5 JP 2021070677A5 JP 2019200346 A JP2019200346 A JP 2019200346A JP 2019200346 A JP2019200346 A JP 2019200346A JP 2021070677 A5 JP2021070677 A5 JP 2021070677A5
- Authority
- JP
- Japan
- Prior art keywords
- hinokinin
- cubebin
- active ingredient
- hyperuricemia
- prophylactic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- DDWGQGZPYDSYEL-LSDHHAIUSA-N hinokinin Chemical compound C1=C2OCOC2=CC(C[C@@H]2[C@@H](CC=3C=C4OCOC4=CC=3)COC2=O)=C1 DDWGQGZPYDSYEL-LSDHHAIUSA-N 0.000 claims 4
- DIYWRNLYKJKHAM-MDOVXXIYSA-N (-)-cubebin Chemical compound C1=C2OCOC2=CC(C[C@@H]2[C@@H](CC=3C=C4OCOC4=CC=3)CO[C@@H]2O)=C1 DIYWRNLYKJKHAM-MDOVXXIYSA-N 0.000 claims 2
- DDWGQGZPYDSYEL-UHFFFAOYSA-N Cubebinolide Natural products C1=C2OCOC2=CC(CC2C(CC=3C=C4OCOC4=CC=3)COC2=O)=C1 DDWGQGZPYDSYEL-UHFFFAOYSA-N 0.000 claims 2
- 239000004480 active ingredient Substances 0.000 claims 2
- XUEHVOLRMXNRKQ-KHMAMNHCSA-N alpha cubebene Natural products CC(C)[C@@H]([C@H]12)CC[C@@H](C)[C@]32[C@@H]1C(C)=CC3 XUEHVOLRMXNRKQ-KHMAMNHCSA-N 0.000 claims 2
- 201000001431 Hyperuricemia Diseases 0.000 claims 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 claims 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 claims 1
- 230000000069 prophylactic effect Effects 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
- 229940116269 uric acid Drugs 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019200346A JP7437731B2 (ja) | 2019-11-02 | 2019-11-02 | 生活習慣病の予防と治療用医薬組成物および飲食品 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019200346A JP7437731B2 (ja) | 2019-11-02 | 2019-11-02 | 生活習慣病の予防と治療用医薬組成物および飲食品 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021070677A JP2021070677A (ja) | 2021-05-06 |
| JP2021070677A5 true JP2021070677A5 (enExample) | 2022-10-14 |
| JP7437731B2 JP7437731B2 (ja) | 2024-02-26 |
Family
ID=75714197
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019200346A Active JP7437731B2 (ja) | 2019-11-02 | 2019-11-02 | 生活習慣病の予防と治療用医薬組成物および飲食品 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP7437731B2 (enExample) |
-
2019
- 2019-11-02 JP JP2019200346A patent/JP7437731B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3999042T3 (da) | Cannabinoidderivater som farmaceutisk aktive forbindelser og fremgangsmåder til fremstilling deraf | |
| WO2017035353A8 (en) | Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disorders | |
| MX392213B (es) | Composiciones farmacéuticas que comprenden sales de glicopirrolato y 1,1-difluoroetano. | |
| HK1256256A1 (zh) | 包含urat1的有效抑制剂的药物组合物 | |
| NZ749427A (en) | Thiophene, manufacturing method thereof, and pharmaceutical application of same | |
| HK1259440A1 (zh) | 包含btk抑制剂的配制品/组合物 | |
| NZ745210A (en) | Novel 2,3,5-substituted thiophene compound as protein kinase inhibitor | |
| NZ598750A (en) | Therapeutic agent for mood disorders | |
| MX2021007069A (es) | 3,3-difluoroalilaminas o sales de las mismas y composiciones farmaceuticas que comprenden las mismas. | |
| PL3207928T3 (pl) | Preparat złożony, zawierający nową pochodną kwasu 3-(4-(benzyloksy)fenylo)heks-4-ynowego oraz inny składnik czynny, przeznaczony do zapobiegania lub leczenia chorób metabolicznych | |
| MX2021010133A (es) | Forma cristalina de 1-(1-oxo-1,2-dihidroisoquinolin-5-il)-5-(trifl uorometil)-n-(2-(trifluorometil)piridin-4-il)-1h-pirazol-4-carbox amida monohidratada. | |
| FI3248597T3 (fi) | Terapeuttinen aine sensorineuraaliseen kuulonmenetykseen | |
| JOP20200100A1 (ar) | مشتقات بيرازولو-بيرولو-بيريميدين-ديون جديدة كمثبِّطات لـ p2x3 | |
| PH12021553202A1 (en) | Analogues of 3-(5-methyl-1,3-thiazol-2-yl)-n-{(1r)-1-[2-(trifluoro-methyl)pyrimidin-5-yl]ethyl}benzamide | |
| HK1257171A1 (zh) | 間變性淋巴瘤激酶（alk）和絲氨酸富集蛋白激酶 （sppk）的抑制劑及其使用方法 | |
| CO2022008616A2 (es) | Composición farmacéutica oral que comprende compuesto de carbamato y método de preparación para la misma | |
| CN112789277A (zh) | 胍类衍生物及其用途 | |
| JP2014218523A5 (enExample) | ||
| CN115666576A (zh) | 一种治疗和/或预防冠状病毒引发的疾病的化合物及其应用 | |
| AU2018258588A8 (en) | Inhibitors of TRIM33 and methods of use | |
| JP2021070677A5 (enExample) | ||
| MX381234B (es) | Agente preventivo y/o terapéutico de enfermedad inmune. | |
| JP2018150270A5 (enExample) | ||
| BR112017004694A2 (pt) | composições farmacêuticas compreendendo alpelisibe | |
| JP2020043851A5 (enExample) |